Atlas Arteria logo

ALX - Atlas Arteria Share Price

A$6.18 0.0  0.5%

Last Trade - 7:10am

Large Cap
Market Cap £3.27bn
Enterprise Value £3.98bn
Revenue £59.1m
Position in Universe 98th / 1911
Unlock ALX Revenue
Relative Strength (%)
1m +0.34%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2.60 2.96 83.3 132.5 175.2 106.7 154.8 143.2 +110.2%
-76.8 +2,119 -89.5 +63.2 -71.2 +1,226 +5.17
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, AtlasArteria Group revenues decreased 39% to A$106.7M. Net lossincreased from A$9.8M to A$55.8M. Revenues reflect DullesGreerway segment decrease of 42% to A$74.8M, OtherUnallocated segment decrease of 68% to A$2.4M. Higher netloss reflects Equity Earnings Net of Income Tax decreaseof 23% to A$196.1M (income), Impairment loss on tollingconcession increase of 45% to A$143.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ALX Revenue Unlock ALX Revenue

Net Income

ALX Net Income Unlock ALX Revenue

Normalised EPS

ALX Normalised EPS Unlock ALX Revenue

PE Ratio Range

ALX PE Ratio Range Unlock ALX Revenue

Dividend Yield Range

ALX Dividend Yield Range Unlock ALX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ALX EPS Forecasts Unlock ALX Revenue
Profile Summary

Atlas Arteria Group, formerly Macquarie Atlas Roads Group, is an Australia-based global infrastructure developer, operator and investor. The Company constructs highways, roads, bridges, and tunnels. The Company's portfolio assets include Autoroutes Paris-Rhin-Rhone (APRR), Dulles Greenway, Warnow Tunnel and M6 Toll. The Company's APRR is a 2,323 kilometers motorway network located in the east of France. The Company’s ADELAC is the concessionaire of the A41 motorway, a 20 kilometre commuter road between Annecy in eastern France and Geneva in Switzerland. The Company's Dulles Greenway is a 22 kilometers toll road in northern Virginia, connecting Loudon County with the greater Washington area. The Company's Warnow Tunnel is a two kilometer toll road and tunnel under the Warnow River in the northern German city of Rostock.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since January 25, 2010
No. of Shareholders: n/a
No. of Employees: n/a
Sector Industrials
Industry Transport Infrastructure
Index S&P/ASX All Ordinaries , S&P/ASX 100 , S&P/ASX 200 , S&P/ASX 300 , S&P/ASX MidCap 50 ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 959,018,000
Free Float (0.0%)
Eligible for
ALX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ALX
Upcoming Events for ALX
Wednesday 19th May, 2021 Estimate
Atlas Arteria Group Annual Shareholders Meeting
Wednesday 21st July, 2021
Q2 2021 Atlas Arteria Group Traffic and Revenue Data
Thursday 26th August, 2021
Half Year 2021 Atlas Arteria Group Earnings Release
Wednesday 20th October, 2021
Q3 2021 Atlas Arteria Group Traffic and Revenue Data
Frequently Asked Questions for Atlas Arteria
What is the Atlas Arteria share price?

As of 7:10am, shares in Atlas Arteria are trading at A$6.18, giving the company a market capitalisation of £3.27bn. This share price information is delayed by 15 minutes.

How has the Atlas Arteria share price performed this year?

Shares in Atlas Arteria are currently trading at A$6.18 and the price has moved by 0.33% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Atlas Arteria price has moved by -23.93% over the past year.

What are the analyst and broker recommendations for Atlas Arteria?

Of the analysts with advisory recommendations for Atlas Arteria, there are there are currently 0 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Atlas Arteria is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Atlas Arteria next release its financial results?

Atlas Arteria is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Atlas Arteria dividend yield?

The Atlas Arteria dividend yield is 3.9% based on the trailing twelve month period.

Does Atlas Arteria pay a dividend?

Last year, Atlas Arteria paid a total dividend of 0.24, and it currently has a trailing dividend yield of 3.9%. Looking ahead, Atlas Arteria has not announced an ex-dividend date yet.

When does Atlas Arteria next pay dividends?

Atlas Arteria has yet to annouce their ex-dividend date. The historic dividend yield on Atlas Arteria shares is currently 3.9%.

How do I buy Atlas Arteria shares?

To buy shares in Atlas Arteria you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Atlas Arteria?

Shares in Atlas Arteria are currently trading at A$6.18, giving the company a market capitalisation of £3.27bn.

Where are Atlas Arteria shares listed? Where are Atlas Arteria shares listed?

Here are the trading details for Atlas Arteria:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ALX
What kind of share is Atlas Arteria?

Based on an overall assessment of its quality, value and momentum, Atlas Arteria is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Atlas Arteria share price forecast 2021?

Shares in Atlas Arteria are currently priced at A$6.18. At that level they are trading at 15.69% discount to the analyst consensus target price of 0.00.

Analysts covering Atlas Arteria currently have a consensus Earnings Per Share (EPS) forecast of 0.542 for the next financial year.

How can I tell whether the Atlas Arteria share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Atlas Arteria. Over the past six months, the relative strength of its shares against the market has been -16.75%. At the current price of A$6.18, shares in Atlas Arteria are trading at -1.11% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Atlas Arteria PE Ratio?

The Atlas Arteria PE ratio based on its reported earnings over the past 12 months is 0.150k. The shares are currently trading at A$6.18.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Atlas Arteria?

Atlas Arteria's management team is headed by:

Jeffrey Conyers - NEC
Debra Goodin - NEC
Graeme Bevans - CEO
Nadine Lennie - CFO
David Bartholomew - NID
Vincent Portal-Barrault - COO
Clayton McCormack - GCN
Fiona Beck - NID
Ariane Barker - NID
Who are the major shareholders of Atlas Arteria?

Here are the top five shareholders of Atlas Arteria based on the size of their shareholding:

Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund
Percentage owned: 11.29% (108.3m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.5% (52.8m shares)
Lazard Global Listed Infrastructure Portfolio Mutual Fund
Percentage owned: 5.1% (48.9m shares)
Pendal Group Limited Investment Advisor
Percentage owned: 4.89% (46.9m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 2.56% (24.6m shares)
Similar to ALX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.